BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 11355001)

  • 1. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cardiac glycosides, a new class of steroid hormones.
    Schoner W
    Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endogenous cardiotonic steroids in sodium homeostasis.
    Schoner W; Scheiner-Bobis G
    Nephrol Dial Transplant; 2008 Sep; 23(9):2723-9. PubMed ID: 18556748
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
    Bagrov AY; Shapiro JI; Fedorova OV
    Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
    Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
    Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.
    Ferrari P; Torielli L; Ferrandi M; Padoani G; Duzzi L; Florio M; Conti F; Melloni P; Vesci L; Corsico N; Bianchi G
    J Pharmacol Exp Ther; 1998 Apr; 285(1):83-94. PubMed ID: 9535997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of sodium pump function in hypertension and the role of endogenous cardiotonic steroids.
    Doris PA
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):391-401. PubMed ID: 11357900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action.
    Quadri L; Bianchi G; Cerri A; Fedrizzi G; Ferrari P; Gobbini M; Melloni P; Sputore S; Torri M
    J Med Chem; 1997 May; 40(11):1561-4. PubMed ID: 9171865
    [No Abstract]   [Full Text] [Related]  

  • 17. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.
    Abramowitz J; Dai C; Hirschi KK; Dmitrieva RI; Doris PA; Liu L; Allen JC
    Circulation; 2003 Dec; 108(24):3048-53. PubMed ID: 14638550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational states of the pig kidney Na
    Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
    Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of cardiac steroids on intracellular membrane traffic in neuronal NT2 cells.
    Rosen H; Glukmann V; Feldmann T; Fridman E; Lichtstein D
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):78-86. PubMed ID: 17535740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
    Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
    FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.